Back
Results - Announcements
Sales rise 7.80% to Rs 70.74 crore
Balaxi Pharmaceuticals consolidated net profit declines 95.52% in the June 2025 quarter
05-Aug-2025, 03:44
Net profit of Balaxi Pharmaceuticals declined 95.52% to Rs 0.29 crore in the quarter ended June 2025 as against Rs 6.48 crore during the previous quarter ended June 2024. Sales rose 7.80% to Rs 70.74 crore in the quarter ended June 2025 as against Rs 65.62 crore during the previous quarter ended June 2024.
Net profit of Balaxi Pharmaceuticals declined 95.52% to Rs 0.29 crore in the quarter ended June 2025 as against Rs 6.48 crore during the previous quarter ended June 2024. Sales rose 7.80% to Rs 70.74 crore in the quarter ended June 2025 as against Rs 65.62 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 70.74 | 65.62 | 8 |
| OPM % | 5.87 | 15.38 | - |
| PBDT | 1.37 | 7.87 | -83 |
| PBT | 0.90 | 7.37 | -88 |
| NP | 0.29 | 6.48 | -96 |
Powered by Capital Market - Live News